Back to top
more

Neogen (NEOG)

(Delayed Data from NSDQ)

$14.44 USD

14.44
1,190,769

+0.16 (1.12%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $14.45 +0.01 (0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

DaVita (DVA) Partners with Epic to Launch EHR for Patients

DaVita (DVA) collaborates with Epic to introduce electronic health record facility for patients, reduce costs and enhance healthcare.

    Can Neogen (NEOG) Stock Continue to Grow Earnings?

    Neogen (NEOG) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.

      Neogen (NEOG) Q2 Earnings Beat Estimates, Revenues Miss

      Neogen (NEOG) rides high on balanced growth across all business segments in Q2.

        Neogen (NEOG) Earnings and Revenues Beat Estimates in Q1

        Neogen (NEOG) rides high on balanced growth across all business segments.

          Neogen Introduces Test for Listeria in Environmental Samples

          Neogen Corporation (NEOG) recently developed Listeria Right Now test system.

            Neogen Offers NeoSeek Genomic Services to Ensure Food Safety

            Headquartered in Lansing, MI, Neogen Corporation (NEOG) recently announced the availability of next generation sequencing services for the food industry.

              Neogen (NEOG) Earnings and Revenues Meet Estimates in Q3

              Neogen Corp (NEOG) reported adjusted earnings of 27 cents per share in the third quarter of fiscal 2017. The figure was in line with the Zacks Consensus Estimate and increased 22.7% from the year-ago quarter.

                Medtronic Initiates BTK Study on DCB for PAD Cure in Europe

                Medtronic plc (MDT) recently initiated the IN.PACT below-the-knee (BTK) study to evaluate the effectiveness of a drug-coated balloon for treatment of peripheral arterial disease (PAD).

                  VWR Corporation (VWR): Q4 Lacks Shine, Currency Woes Remain

                  On Mar 9, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR) -- a global provider of products, services and solutions to laboratory and production facilities.

                    Walgreens Boots Grapples with Headwinds: Should You Dump?

                    On Mar 8, we issued an updated research report on Illinois-based leading pharmacy-led, health and wellbeing enterprise Walgreens Boots Alliance, Inc. (WBA).

                      CVS Health Adopts Epic EHR for Specialty Care Programs

                      CVS Health Corporation (CVS) recently announced that it has chosen Epic as the electronic health record (EHR) system for CVS Specialty's care management programs.

                        BioScrip (BIOS): Q4 Loss Narrower than Expected, Sales Top

                        BioScrip, Inc. (BIOS) reported net loss from continuing operations of $5.2 million or loss of 6 cents per share in the fourth quarter of 2016, much narrower than the year-ago net loss of $16.9 million or loss of 28 cents.

                          Amedisys Stock Up on Solid Earnings, Reimbursement Woes Stay

                          On Mar 02, we issued an updated research report on renowned home health and hospice services provider Amedisys Inc. (AMED).

                            VWR Corp Poised on Strong Earnings Amid Currency Headwinds

                            On Feb 28, we issued an updated research report on VWR Corporation (VWR), an independent worldwide provider of products, services and solutions to laboratory and production facilities.

                              Baxter Partners ScinoPharm, Expands in Generic Injectables

                              Baxter International Inc. (BAX) has formed a strategic partnership with Taiwan-based process R&D and active pharmaceutical ingredient (API) manufacturer, ScinoPharm Taiwan, Ltd.

                                Hill-Rom Holdings Hits a 52-Week High on Solid Prospects

                                Share price of Batesville, IN-based Hill-Rom Holdings, Inc.(HRC) scaled a new 52-week high of $67.44 on Mar 1, eventually closing a tad lower at $67.21.

                                  Amedisys Buys 6 Home Health, Hospice Care Centers from Tenet

                                  Amedisys Inc. (AMED), a household name in home health and hospice services space, recently signed an exclusive agreement with Tenet Healthcare Corporation (THC).

                                    Penumbra (PEN) Q4 Loss Narrower than Expected, Sales Top

                                    Penumbra, Inc. (PEN), that went public in Sep 2015, reported fourth-quarter 2016 loss of 8 cents per share, down from earnings of 5 cents per share year over year.

                                      Mead Johnson Acquires Bega's Strategic Capabilities Business

                                      Mead Johnson Nutrition Company (MJN) recently inked an agreement with Bega Cheese Limited to acquire the latter's spray drying and finishing capabilities business in Australia.

                                        Amedisys (AMED) Earnings Top Q4 Estimates, Revenues Lag

                                        Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 44 cents per share in the fourth quarter of 2016, up 10% year over year.

                                          Medtronic (MDT) Presents 5-Year Cost Data of CRT Devices

                                          Medtronic plc (MDT) recently presented a five-year data report on cardiac resynchronization therapy (CRT) devices within its Cardiac Rhythm & Heart Failure (CRHF) division.

                                            VWR Corporation (VWR) Tops Earnings in Q4; View Dull

                                            VWR Corporation (VWR) reported fourth-quarter 2016 adjusted earnings per share (EPS) of 45 cents, reflecting a 4.3% decline from the year-ago quarter.

                                              Integra (IART) Posts In-Line Q4 Earnings, Issues 2017 View

                                              Integra LifeSciences Holdings Corporation (IART) reported adjusted earnings per share of 52 cents in the fourth quarter of 2016, up 18% from the year-ago adjusted number.

                                                Medtronic Poised on Strong Fundamentals Despite Several Woes

                                                On Feb 23, we issued an updated research report on medical device major, Medtronic plc (MDT).

                                                  Omnicell: Q4 Report Disappoints, Aesynt Buyout Holds Promise

                                                  On Feb 22, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).